The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-{(S)-2-[(S)-2-{(S)-2-[(S)-2-Amino-3-(1H-indol-3-yl)-propionylamino]-5-guanidino-pentanoylamino}-3-(1H-indol-3-yl)-propionylamino]-5-guanidino-pentanoylamino}-3-(1H-indol-3-yl)-propionic acid ID: ALA4082081
PubChem CID: 137648832
Max Phase: Preclinical
Molecular Formula: C45H56N14O6
Molecular Weight: 889.03
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
Standard InChI: InChI=1S/C45H56N14O6/c46-31(19-25-22-53-32-12-4-1-9-28(25)32)39(60)56-35(15-7-17-51-44(47)48)40(61)58-37(20-26-23-54-33-13-5-2-10-29(26)33)42(63)57-36(16-8-18-52-45(49)50)41(62)59-38(43(64)65)21-27-24-55-34-14-6-3-11-30(27)34/h1-6,9-14,22-24,31,35-38,53-55H,7-8,15-21,46H2,(H,56,60)(H,57,63)(H,58,61)(H,59,62)(H,64,65)(H4,47,48,51)(H4,49,50,52)/t31-,35-,36-,37-,38-/m0/s1
Standard InChI Key: MYSIKIHYRKBENF-DUKNTCSXSA-N
Molfile:
RDKit 2D
65 70 0 0 0 0 0 0 0 0999 V2000
24.2812 -10.5249 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0100 -10.1388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6838 -11.3942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7111 -10.5735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0348 -9.3129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5056 -9.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7610 -8.9215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0778 -8.6863 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8764 -8.1055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6864 -7.9601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9645 -7.1868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4339 -6.5550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6240 -6.7004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3445 -7.4775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4888 -13.1329 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4601 -13.9575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7338 -14.3488 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.1613 -14.3922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4374 -10.1822 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1386 -10.6169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8883 -9.4034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8648 -10.2255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1098 -11.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8111 -11.8761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7876 -12.6982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5660 -10.6601 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2909 -10.2727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9672 -11.5333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9921 -10.7074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3157 -9.4467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7865 -9.4173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0444 -9.0607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3573 -8.8240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.1559 -8.2431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9673 -8.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2454 -7.3206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7148 -6.6888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9034 -6.8381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6254 -7.6113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7683 -13.2707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7435 -14.0966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0147 -14.4827 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.4408 -14.5298 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7183 -10.3160 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4195 -10.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1731 -9.5386 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1442 -10.3633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3946 -11.5767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0920 -12.0100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0671 -12.8360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8455 -10.7979 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5717 -10.4065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2481 -11.6672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.2730 -10.8412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5991 -9.5859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0714 -9.5526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3253 -9.1945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6382 -8.9579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.4407 -8.3785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2507 -8.2331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5302 -7.4560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9982 -6.8280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1843 -6.9719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9049 -7.7491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0017 -10.4552 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4 19 1 0
22 26 1 0
29 44 1 0
47 51 1 0
54 65 1 0
1 2 1 0
2 4 1 0
4 3 2 0
2 5 1 1
5 7 1 0
6 7 2 0
7 9 1 0
8 6 1 0
10 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
15 16 1 0
16 17 1 0
16 18 2 0
19 20 1 0
20 22 1 0
22 21 2 0
20 23 1 6
23 24 1 0
24 25 1 0
25 15 1 0
26 27 1 0
27 29 1 0
29 28 2 0
27 30 1 1
30 32 1 0
31 32 2 0
32 34 1 0
33 31 1 0
35 33 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 34 1 0
40 41 1 0
41 42 1 0
41 43 2 0
44 45 1 0
45 47 1 0
47 46 2 0
45 48 1 6
48 49 1 0
49 50 1 0
50 40 1 0
51 52 1 0
52 54 1 0
54 53 2 0
52 55 1 1
55 57 1 0
56 57 2 0
57 59 1 0
58 56 1 0
60 58 1 0
59 60 2 0
60 61 1 0
61 62 2 0
62 63 1 0
63 64 2 0
64 59 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 889.03Molecular Weight (Monoisotopic): 888.4507AlogP: 1.04#Rotatable Bonds: 23Polar Surface Area: 350.89Molecular Species: ZWITTERIONHBA: 8HBD: 15#RO5 Violations: 2HBA (Lipinski): 20HBD (Lipinski): 18#RO5 Violations (Lipinski): 3CX Acidic pKa: 3.97CX Basic pKa: 12.00CX LogP: -1.35CX LogD: -3.76Aromatic Rings: 6Heavy Atoms: 65QED Weighted: 0.02Np Likeness Score: 0.13
References 1. Eksteen JJ, Ausbacher D, Simon-Santamaria J, Stiberg T, Cavalcanti-Jacobsen C, Wushur I, Svendsen JS, Rekdal Ø.. (2017) Iterative Design and in Vivo Evaluation of an Oncolytic Antilymphoma Peptide., 60 (1): [PMID:28004928 ] [10.1021/acs.jmedchem.6b00839 ]